Editorial Team (ET)

Trump’s sweeping Section 232 probe on critical mineral imports aims to curb U.S. dependence on China while unlocking massive opportunity for North American producers.

Costco’s latest 12.1% dividend hike highlights its financial muscle—but is the stock still a buy at these levels?

Bruce Murray says the worst is over and names Meta, Eli Lilly, and Linamar as strategic buys for a market ready to rebound.

How UnitedHealth’s 23% crash exposed the Dow’s outdated formula—and shook 800 points off the index in a single session.

China’s rare earth export controls mark a new phase in economic warfare—threatening to destabilize global supply chains and challenge America’s tech and defense dominance.

U.S. export ban blindsides Nvidia, triggering a multibillion-dollar write-down, shaking markets, and sparking renewed tech war fears with China.

After a historic rally, gold has eclipsed the tech elite as investors flock to safety amid economic uncertainty, geopolitical tension, and fading faith in U.S. exceptionalism.

Raymond James’ Chris Blumas doubles down on defensive giants with cash flow, capital, and global reach amid mounting market turmoil.

Qube Research drops a bombshell with a $105 million short position against Trump Media, raising questions about valuation, volatility, and political loyalty on Wall Street.

Barometer Capital's David Burrows plays defense with gold, gas, and cash as market leadership shifts beyond U.S. borders.